Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors. - Test2 - elhamkhani - TriplyDB

Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors.

Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors.

http://www.wikidata.org/entity/Q33957283

about

Efficacy of Carraguard-based microbicides in vivo despite variable in vitro activity Animal Models for HIV Cure Research Animal and human mucosal tissue models to study HIV biomedical interventions: can we predict success?Considerations in the development of nonhuman primate models of combination antiretroviral therapy for studies of AIDS virus suppression, residual virus, and curative strategies Rectal pre-exposure prophylaxis (PrEP)A macaque model to study vaginal HSV-2/immunodeficiency virus co-infection and the impact of HSV-2 on microbicide efficacy Persistence of viral reservoirs in multiple tissues after antiretroviral therapy suppression in a macaque RT-SHIV model An antiretroviral/zinc combination gel provides 24 hours of complete protection against vaginal SHIV infection in macaques Residual viremia in an RT-SHIV rhesus macaque HAART model marked by the presence of a predominant plasma clone and a lack of viral evolution Exposure to MIV-150 from a high-dose intravaginal ring results in limited emergence of drug resistance mutations in SHIV-RT infected rhesus macaques Why primate models matter.Animal models for HIV/AIDS research Macaques as model hosts for studies of HIV-1 infection Prophylactic and therapeutic effect of AZT/3TC in RT-SHIV infected Chinese-origin rhesus macaques Immunotoxin complementation of HAART to deplete persisting HIV-infected cell reservoirs Viral decay kinetics in the highly active antiretroviral therapy-treated rhesus macaque model of AIDS.Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS Antiretroviral therapy during primary immunodeficiency virus infection can induce persistent suppression of virus load and protection from heterologous challenge in rhesus macaques.Enhanced antiretroviral therapy in rhesus macaques improves RT-SHIV viral decay kinetics Evidence for recombination of live, attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain.Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses r Suppression of virus load by highly active antiretroviral therapy in rhesus macaques infected with a recombinant simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1.Characteristics of a pathogenic molecular clone of an end-stage serum-derived variant of simian immunodeficiency virus (SIV(F359)).Human and simian immunodeficiency virus capsid proteins are major viral determinants of early, postentry replication blocks in simian cells.Susceptibilities of simian immunodeficiency virus to protease inhibitors The nonnucleoside reverse transcriptase inhibitor MIV-150 in carrageenan gel prevents rectal transmission of simian/human immunodeficiency virus infection in macaques.Rhesus macaque polyclonal and monoclonal antibodies inhibit simian immunodeficiency virus in the presence of human or autologous rhesus effector cells.Analysis of multiply spliced transcripts in lymphoid tissue reservoirs of rhesus macaques infected with RT-SHIV during HAART Latent HIV-1 infection of resting CD4⁺ T cells in the humanized Rag2⁻/⁻ γc⁻/⁻ mouse Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection.Low Frequency of Drug-Resistant Variants Selected by Long-Acting Rilpivirine in Macaques Infected with Simian Immunodeficiency Virus Containing HIV-1 Reverse Transcriptase.Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy.Breaking Barriers to an AIDS Model with Macaque-Tropic HIV-1 Derivatives.Macaque models of human infectious disease.A macaque model of HIV-1 infection Nonhuman primate models of NeuroAIDS Macaca mulatta, fascicularis and nemestrina in AIDS vaccine development.RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models.Infection of rhesus macaques with a pool of simian immunodeficiency virus with the envelope genes from acute HIV-1 infections.Efavirenz therapy in rhesus macaques infected with a chimera of simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1.

P2860

Q21562543-6051B6FC-D50E-48BD-9BF6-942689DEB601 Q26767476-A589931E-0859-4A05-8E5D-A119AF64AF24 Q26777022-F1A4DBD2-47E3-4BB3-843B-E5A58CFD36D5 Q26825814-32F4E2EC-3AE0-4E23-80DF-AFB0B11A06AB Q26829713-6236E300-EE26-41FE-9669-3690E8C262FE Q27335068-0F49C545-CA57-4900-8960-B56F5EA7A8C7 Q27335485-9A86A237-4695-4F05-A5A7-DFE20781F932 Q27438093-833C6B1B-590C-4D2F-B7E3-56EE2F5915FA Q28539563-0A301462-8BD4-4C8D-810A-A80DFDC15C71 Q28540200-A3426043-EDF0-4B47-8224-7FB18ACD5987 Q30417520-DEA395CE-5FC0-4BA9-9895-B815299ABF80 Q30423656-A21256BE-2E60-4D9E-9DD4-A3E0F89743DE Q30653348-ECBA71D7-86A9-4035-A3CB-8FAA5B333482 Q33592750-C81BBD59-E888-4D62-981D-71AA8C53B323 Q33604776-7B14C3BB-34A7-4076-8161-97B5E356C4FF Q33644248-5ED7D740-9996-4129-8139-C6E7F85F1B1D Q33676630-575648C3-17A5-4E75-9A4F-B246353DA512 Q33797315-833AB096-C355-45B7-A149-076A4BC65F8E Q33798207-C92832BC-CC89-47D4-A565-7A4D4F64B243 Q33802066-97525B87-2CE4-4DCF-920A-9E1C7D310B17 Q33806166-4EACC1D3-EA19-4BA8-BBEA-11539CAB7381 Q33843148-C2B8651C-0202-4C5C-A5B4-7ACEE4193DD0 Q33845764-D0CD791E-0100-4007-90C1-B4AAA75085B4 Q34462276-5829B984-CE37-4432-842F-8B9B49345049 Q34939250-61E82FBB-BE2B-493C-93F6-32D655C7401A Q34982693-504E79B4-B3C7-485C-B881-ED316118C7CE Q35024276-F73FBCA6-AB5E-4716-A685-676A95C28B5B Q35088292-D689E018-ADF8-4658-858E-5512C75B9C39 Q35665924-76F484DF-72BF-4C1F-A537-A466D0C280F5 Q35752812-64957537-3048-494F-AC6B-A16CF128C3EB Q36290753-53D4CCFA-48BE-4195-AC26-AE002958BC5B Q36315555-0E25868E-AD1D-4BEB-8F2A-D23B15B56107 Q36537806-0AE3E6B9-EC4F-4179-AA0B-A094613F5525 Q37103536-718D482C-5B4A-404B-BBDD-B795ECD555A4 Q37132808-F14A746C-57BA-4A99-8CE7-A505FBA2977B Q37264017-8946F340-8C4A-4430-8748-08EDF6C1236D Q37316026-93CF1C37-D1FF-4A9C-A815-91617308E9F4 Q37428359-AF3E0DC5-C107-44EC-A6DD-C486CE0ABAEB Q37442592-B7114943-BB6B-4784-B474-AAD289EC8572 Q37489188-2BDB2D6D-C501-4DE6-9694-5876610212D8

P2860

Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors.

http://www.wikidata.org/entity/Q33957283

description

1995 nî lūn-bûn

@nan

1995 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

Animal model for the therapy o ...... erse transcriptase inhibitors.

@ast

Animal model for the therapy o ...... erse transcriptase inhibitors.

@en

type

label

Animal model for the therapy o ...... erse transcriptase inhibitors.

@ast

Animal model for the therapy o ...... erse transcriptase inhibitors.

@en

prefLabel

Animal model for the therapy o ...... erse transcriptase inhibitors.

@ast

Animal model for the therapy o ...... erse transcriptase inhibitors.

@en

P1433

Q33957283-AD89DB5A-910C-4722-B51C-D52930C31BEA

P1476

Q33957283-C5F84960-CC40-4A74-A468-D664548F8E43

P2093

Q33957283-02BF1B51-9C56-4160-8EEE-98FE0FED548E

Q33957283-298C1493-23E6-4BE9-BC84-B47D7BB88AB4

Q33957283-45E05BA8-DD78-459D-B48A-B69FBE49CAF6

Q33957283-62CD70AF-EFEE-4BCC-A0AB-F1A78798FD25

Q33957283-83EF5BA1-869D-4D46-AF4B-9BAC0BAB3B52

Q33957283-874C3197-71EB-40F2-B020-CF6EF8403B38

Q33957283-8E6F0D6D-A02E-40BB-8A46-FAF0B0155F32

Q33957283-A89CA036-3810-460E-8994-732FA490F057

Q33957283-B905C1E0-57B6-4811-8704-999913858221

Q33957283-CADE5DDF-B553-4A95-8347-42D21F60B226

P2860

Q33957283-02E33A83-ACBC-435F-A545-D9DEB044AEEA

Q33957283-0E1AD67E-90FA-44EE-BD09-4B9CE69CD6A7

Q33957283-0F395888-4872-4892-B008-CD644ECE78DC

Q33957283-160386CF-D2C8-42B5-B6CF-76A269F3E1E1

Q33957283-1AE41C1C-9A65-4F18-9DB6-A717C15CB4DE

Q33957283-28F530A8-1D0E-43CD-B725-3907EB28FBA5

Q33957283-2C323C19-2335-42F0-B0E2-A575B0C6A524

Q33957283-2FBDF27F-B38F-49AB-A0CB-54DC548F6351

Q33957283-40E3F37D-EB68-4A31-8B66-76FC65A28DB4

Q33957283-4CE7572F-6692-4F41-892E-9F28B66CA50B

P304

Q33957283-8719E99A-2A8D-485E-842A-414C7D08DD6E

P31

Q33957283-1879A24C-E51C-49E5-BB42-85AAEEE7883A

P356

Q33957283-F265DF1C-4678-4990-A8FC-D8E152EAD9E0

P407

Q33957283-1D7D85DD-65DC-4F65-9FEF-743963F3FBE5

P433

Q33957283-F0D0FB79-CEFC-4227-9FB3-2236F0F56E0C

P478

Q33957283-F27E4008-D3BF-4937-9527-F7EA4CE6F224

P577

Q33957283-C3274A39-5792-4DB8-9534-09E40B3F69E2

P5875

Q33957283-00B27ADB-E488-488F-A2CE-6AC3060799E3

P698

Q33957283-54C03FD4-02BF-4C47-A417-85FA38411204

P932

Q33957283-48F50000-72A6-4D54-8E67-63C2198DF629

P356

PNAS.92.18.8210

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Animal model for the therapy o ...... erse transcriptase inhibitors.

@en

P2093

Böttiger D

http://www.w3.org/2001/XMLSchema#string

Fleckenstein B

http://www.w3.org/2001/XMLSchema#string

Haseltine WA

http://www.w3.org/2001/XMLSchema#string

Hunsmann G

http://www.w3.org/2001/XMLSchema#string

Kaup FJ

http://www.w3.org/2001/XMLSchema#string

Li J

http://www.w3.org/2001/XMLSchema#string

Mätz-Rensing K

http://www.w3.org/2001/XMLSchema#string

Oberg B

http://www.w3.org/2001/XMLSchema#string

Stahl-Hennig C

http://www.w3.org/2001/XMLSchema#string

Uberla K

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor

Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase

In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine

Antiviral effects of 3'-fluorothymidine and 3'-azidothymidine in cynomolgus monkeys infected with simian immunodeficiency virus

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)

Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidine

Importance of the nef gene for maintenance of high virus loads and for development of AIDS

Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus.

Isolation of T-cell tropic HTLV-III-like retrovirus from macaques.

P304

8210-8214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.92.18.8210

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

92

http://www.w3.org/2001/XMLSchema#string

P577

1995-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15654413

http://www.w3.org/2001/XMLSchema#string

P698

7545297

http://www.w3.org/2001/XMLSchema#string

P932

41126

http://www.w3.org/2001/XMLSchema#string